Impact of Basolateral Multidrug Resistance-Associated Protein (Mrp) 3 and Mrp4 on the Hepatobiliary Disposition of Fexofenadine in Perfused Mouse Livers
Authors:
- Brandon SwiftBSBrandon Swift
- Maciej J. Zamek-GliszczynskiMZMaciej J. Zamek-Gliszczynski
- Martin G. BelinskyMBMartin G. Belinsky
- Gary D. KruhGKGary D. Kruh
- Kim L. R. BrouwerKBKim L. R. Brouwer
- 1 May 2008
- journal article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 36 (5) , 911-915
Abstract
The disposition of fexofenadine, a commonly used antihistamine drug, is governed primarily by active transport. Biliary excretion of the parent compound is the major route of systemic clearance. Previous studies demonstrated that fexofenadine hepatic uptake is mediated by organic anion transporting polypeptides. Recently, we showed that in mice fexofenadine is excreted into bile primarily by multidrug resistance-associated protein (Mrp) 2 (Abcc2). In the present study, the roles of Mrp3 (Abcc3) and Mrp4 (Abcc4) in the hepatobiliary disposition of fexofenadine were examined in knockout mice using in situ liver perfusion. Compared with that in wild-type mice, basolateral excretion of fexofenadine was impaired, resulting in a ∼50% decrease in perfusate recovery in Abcc3-/- mice; in contrast, fexofenadine hepatobiliary disposition was unaltered in Abcc4-/- mice. As expected, in Abcc2-/- mice, fexofenadine was redirected from the canalicular to the basolateral membrane for excretion. In Abcc2-/-/Abcc3-/- double-knockout mice, fexofenadine biliary excretion was impaired, but perfusate recovery was similar to that in wild-type mice and more than 2-fold higher than that in Abcc3-/- mice, presumably due to compensatory basolateral transport mechanism(s). These results demonstrate that multiple transport proteins are involved in the hepatobiliary disposition of fexofenadine. In addition to Mrp2 and Mrp3, other transport proteins play an important role in the biliary and hepatic basolateral excretion of this zwitterionic drug.Keywords
This publication has 28 references indexed in Scilit:
- The effect of short- and long-term administration of verapamil on the disposition of cytochrome P450 3A and P-glycoprotein substratesClinical Pharmacology & Therapeutics, 2006
- Pharmacokinetic Interactions of Drugs with St John’s WortJournal of Psychopharmacology, 2004
- Interactions between Hepatic Mrp4 and Sult2a as Revealed by the Constitutive Androstane Receptor and Mrp4 Knockout MiceJournal of Biological Chemistry, 2004
- Multidrug resistance-associated protein 4 is up-regulated in liver but down-regulated in kidney in obstructive cholestasis in the ratJournal of Hepatology, 2004
- Cotransport of Reduced Glutathione With Bile Salts by Mrp4 (Abcc4) Localized to the Basolateral Hepatocyte MembraneHepatology, 2003
- Pharmacokinetics of 5 (and 6)-Carboxy-2′,7′-Dichlorofluorescein and Its Diacetate Promoiety in the LiverThe Journal of Pharmacology and Experimental Therapeutics, 2003
- Mechanisms of Impaired Biliary Excretion of Acetaminophen Glucuronide after Acute Phenobarbital Treatment or Phenobarbital PretreatmentDrug Metabolism and Disposition, 2002
- Grapefruit Juice Reduces the Oral Bioavailability of Fexofenadine But Not DesloratadineClinical Pharmacokinetics, 2002
- Altered Hepatobiliary Disposition of Acetaminophen Glucuronide in Isolated Perfused Livers from Multidrug Resistance-Associated Protein 2-Deficient TR− RatsThe Journal of Pharmacology and Experimental Therapeutics, 2000
- Characterization of the 5′‐flanking region of the human multidrug resistance protein 2 (MRP2) gene and its regulation in comparison withthe multidrug resistance protein 3 (MRP3) geneEuropean Journal of Biochemistry, 2000